These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi. Mungo C, Guliam A, Chinula L, Inturrisi F, Msowoya L, Mkochi T, Jawadu S, de Sanjosé S, Schiffman M, Tang JH, Smith JS. Infect Agent Cancer; 2024 May 17; 19(1):24. PubMed ID: 38760798 [Abstract] [Full Text] [Related]
5. Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi. Mungo C, Guliam A, Chinula L, Inturrisi F, Msowoya L, Mkochi T, Jawadu S, de Sanjosé S, Schiffman M, Tang JH, Smith JS. medRxiv; 2024 Feb 23. PubMed ID: 38617305 [Abstract] [Full Text] [Related]
8. Lower cost strategies for triage of human papillomavirus DNA-positive women. Qiao YL, Jeronimo J, Zhao FH, Schweizer J, Chen W, Valdez M, Lu P, Zhang X, Kang LN, Bansil P, Paul P, Mahoney C, Berard-Bergery M, Bai P, Peck R, Li J, Chen F, Stoler MH, Castle PE. Int J Cancer; 2014 Jun 15; 134(12):2891-901. PubMed ID: 24248915 [Abstract] [Full Text] [Related]
11. Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea. Toliman PJ, Kaldor JM, Badman SG, Gabuzzi J, Silim S, Kumbia A, Kombuk B, Kombati Z, Munnull G, Guy R, Vallely LM, Kelly-Hanku A, Wand H, Ryan C, Tan G, Brotherton J, Saville M, Mola GDL, Garland SM, Tabrizi SN, Vallely AJ. Papillomavirus Res; 2018 Dec 15; 6():70-76. PubMed ID: 30391365 [Abstract] [Full Text] [Related]
12. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J. Health Technol Assess; 2014 Apr 15; 18(23):1-196. PubMed ID: 24762804 [Abstract] [Full Text] [Related]
13. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J. Vaccine; 2012 Nov 20; 30 Suppl 5():F88-99. PubMed ID: 23199969 [Abstract] [Full Text] [Related]
15. [A study of cervical cancer screening algorithms]. Zhao FH, Zhang WH, Pan QJ, Zhang X, Chen W, Liu B, Ma JF, Hu SY, Qiao YL. Zhonghua Zhong Liu Za Zhi; 2010 Jun 20; 32(6):420-4. PubMed ID: 20819481 [Abstract] [Full Text] [Related]
17. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT. Gilham C, Sargent A, Kitchener HC, Peto J. Health Technol Assess; 2019 Jun 20; 23(28):1-44. PubMed ID: 31219027 [Abstract] [Full Text] [Related]
18. Validity and reliability of using a self-lavaging device for cytology and HPV testing for cervical cancer screening: findings from a pilot study. Jones HE, Mansukhani MM, Tong GX, Westhoff CL. PLoS One; 2013 Jun 20; 8(12):e82115. PubMed ID: 24376516 [Abstract] [Full Text] [Related]
19. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. JAMA; 2000 Jan 05; 283(1):81-6. PubMed ID: 10632284 [Abstract] [Full Text] [Related]
20. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method. Zhao FH, Lewkowitz AK, Chen F, Lin MJ, Hu SY, Zhang X, Pan QJ, Ma JF, Niyazi M, Li CQ, Li SM, Smith JS, Belinson JL, Qiao YL, Castle PE. J Natl Cancer Inst; 2012 Feb 08; 104(3):178-88. PubMed ID: 22271765 [Abstract] [Full Text] [Related] Page: [Next] [New Search]